GR3036538T3 - Improvements in platinum complexes. - Google Patents

Improvements in platinum complexes.

Info

Publication number
GR3036538T3
GR3036538T3 GR20010401212T GR20010401212T GR3036538T3 GR 3036538 T3 GR3036538 T3 GR 3036538T3 GR 20010401212 T GR20010401212 T GR 20010401212T GR 20010401212 T GR20010401212 T GR 20010401212T GR 3036538 T3 GR3036538 T3 GR 3036538T3
Authority
GR
Greece
Prior art keywords
platinum complexes
cycloalkyl
aryl
alkyl
different
Prior art date
Application number
GR20010401212T
Other languages
English (en)
Inventor
Christopher Francis Ja Barnard
Gerald Edward Bossard
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of GR3036538T3 publication Critical patent/GR3036538T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR20010401212T 1994-04-26 2001-09-06 Improvements in platinum complexes. GR3036538T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408218A GB9408218D0 (en) 1994-04-26 1994-04-26 Improvements in platinum complexes

Publications (1)

Publication Number Publication Date
GR3036538T3 true GR3036538T3 (en) 2001-12-31

Family

ID=10754111

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401212T GR3036538T3 (en) 1994-04-26 2001-09-06 Improvements in platinum complexes.

Country Status (12)

Country Link
US (1) US5519155A (el)
EP (1) EP0679656B1 (el)
JP (1) JPH0840892A (el)
AT (1) ATE205216T1 (el)
AU (1) AU692521B2 (el)
CA (1) CA2147567C (el)
DE (1) DE69522490T2 (el)
DK (1) DK0679656T3 (el)
ES (1) ES2162897T3 (el)
GB (1) GB9408218D0 (el)
GR (1) GR3036538T3 (el)
PT (1) PT679656E (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
WO2005077385A2 (en) 2004-02-18 2005-08-25 Gpc Biotech Ag Methods for treating resistant or refractory tumors
US20080146555A1 (en) 2004-06-18 2008-06-19 Gpc Biotech, Inc Uses of Kinase Inhibitors and Compositions Thereof
EP1781230A1 (en) * 2004-07-14 2007-05-09 GPC Biotech AG Variable-dose packaging system
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100310661A1 (en) * 2007-07-16 2010-12-09 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
WO2009032172A2 (en) * 2007-08-31 2009-03-12 Massachusetts Institute Of Technology Platinum compositions as treatment for oct-related cancers
EP2244714A4 (en) * 2008-02-08 2012-06-06 Poniard Pharmaceuticals Inc USE OF PICOPLATIN AND BEVACIZUMAB TO TREAT COLORECTAL CANCER
US9265747B2 (en) 2008-08-26 2016-02-23 Massachusetts Institute Of Technology Platinum (IV) complexes for use in dual mode pharmaceutical therapy
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
US20120238488A1 (en) 2009-09-08 2012-09-20 Konstantinos Alevizopoulos Compounds and methods for treating neoplasia
WO2012013816A1 (en) 2010-07-30 2012-02-02 Medexis S.A. Compounds and methods for treating neoplasia
WO2012177935A1 (en) 2011-06-21 2012-12-27 Massachusetts Inistitute Of Technology Compositions and methods for the treatment of cancer
US8729286B2 (en) 2012-05-10 2014-05-20 Massachusetts Institute Of Technology Platinum compounds as treatment for cancers, and related methods, kits, and compositions
US9133225B2 (en) 2013-03-13 2015-09-15 Massachusetts Institute Of Technology Dual targeting anticancer agents
WO2014165782A2 (en) 2013-04-05 2014-10-09 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113054T1 (de) * 1988-02-02 1994-11-15 Johnson Matthey Inc Pt(iv) komplexe.

Also Published As

Publication number Publication date
US5519155A (en) 1996-05-21
CA2147567A1 (en) 1995-10-27
AU1766195A (en) 1995-11-02
EP0679656A1 (en) 1995-11-02
DE69522490D1 (de) 2001-10-11
JPH0840892A (ja) 1996-02-13
DE69522490T2 (de) 2002-05-16
GB9408218D0 (en) 1994-06-15
PT679656E (pt) 2001-12-28
DK0679656T3 (da) 2001-10-01
EP0679656B1 (en) 2001-09-05
ATE205216T1 (de) 2001-09-15
ES2162897T3 (es) 2002-01-16
AU692521B2 (en) 1998-06-11
CA2147567C (en) 2006-01-17

Similar Documents

Publication Publication Date Title
GB9408218D0 (en) Improvements in platinum complexes
Korytowski et al. Mechanism of dismutation of superoxide produced during autoxidation of melanin pigments
NO890426L (no) Platina(iv)komplekser.
TR200000896T2 (tr) Amidokarboksilik asit türevleri.
AU4225896A (en) Improvements in PT complexes
EP0467206A3 (en) Dicarboxylique acid imides, process for their preparation and their use as herbicides
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
TR199700354A2 (xx) Karbohidrat t�revleri.
WO2000010543A3 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
ES8505996A1 (es) Procedimiento para la preparacion de derivados de sulfenamida
NZ292108A (en) [1,2,4]triazolo[4,3-a]quinoxaline derivatives and medicaments
AU5553898A (en) 1,3-diphosphinopropane ligands and transition metal complexes formed therefrom, their preparation and use
AU1032197A (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds
BR9815178A (pt) Autoimunosupressor e/ou potencializador mediado pelo aumento de células nkt, composto e processo para sua produção
CA2209486A1 (en) Preparation of 3,5-diarylpyrazoles